CCM
Concord Medical Services Holdings
NYSE: CCM · HEALTHCARE · MEDICAL CARE FACILITIES
$5.50
-5.53% today
Updated 2026-06-05
Market cap
$20.19M
P/E ratio
—
P/S ratio
0.04x
EPS (TTM)
$-3.15
Dividend yield
—
52W range
$3 – $7
Volume
0.0M
WallStSmart proprietary scores
43
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+5.5
Quality
C+2.0
Profitability
F7.7
Valuation
B+6/9
Piotroski F-Score
Moderate
-1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$1.20
-78.18%
12-Month target
—
—
Intrinsic (DCF)
$11.95
Margin of safety
+67.95%
Price chart
Stock snapshot
Strengths
+ Revenue growth 57.40% QoQ
+ 67.95% below intrinsic value
+ Debt/equity -1.73x — low leverage
Risks
- Altman Z -0.95 — distress zone
- Thin margins at -20.20%
- Negative free cash flow $-293.16M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $472.08M | $537.40M | $383.96M | $460.51M | $460.51M |
| Net income | $-489.66M | $-297.66M | $-308.24M | $-92.81M | $-64.46M |
| EPS | — | — | — | — | $-3.15 |
| Free cash flow | $-600.47M | $-392.17M | $-808.58M | $-293.16M | $-293.16M |
| Profit margin | -103.72% | -55.39% | -80.28% | -20.15% | -20.20% |
Peer comparison
Smart narrative
Concord Medical Services Holdings trades at $5.50. Our Smart Value Score of 43/100 indicates the stock is fair. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -0.95, it sits in the distress. TTM revenue stands at $460.51M. with profit margins at -20.20%. Our DCF model estimates intrinsic value at $11.95.
Frequently asked questions
What is Concord Medical Services Holdings's stock price?
Concord Medical Services Holdings (CCM) trades at $5.50, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Concord Medical Services Holdings overvalued?
Concord Medical Services Holdings carries a Smart Value Score of 43/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $11.95 versus the $5.50 price, a 68.0% margin of safety on a cash flow basis.
What is the price target of Concord Medical Services Holdings (CCM)?
The 12-month analyst consensus target is $1.20, about 78.2% below the current $5.50. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Concord Medical Services Holdings (CCM)?
Our DCF model estimates intrinsic value at $11.95, a +68.0% margin of safety versus today's $5.50. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Concord Medical Services Holdings's revenue?
Concord Medical Services Holdings's trailing twelve-month revenue is $460.51M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Concord Medical Services Holdings's Altman Z-Score is -0.95, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryChina
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.04x
ROE-21.90%
Beta-0.98
50D MA$4.37
200D MA$4.61
Shares out0.00B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—